InflaRx has dosed the first patient in an adaptive randomized controlled clinical study with IFX‑1 in patients with severe COVID-19 pneumonia in the Netherlands InflaRx received
An exogenous shock, and Covid-19 certainly is a large one, creates a high degree of unforeseen uncertainty for companies and investors alike. Investments that are continuously marked
The Jena-based marketing tech start-up has completed a seven-figure growth financing round. In addition to a number of angel investors, bm|t, MBG Thuringia and Sparkasse
The Jena start-up receives new financing from Carsten Maschmeyer´s seed + speed, the HDI Group, Smart Infrastructure Ventures and existing Investors The Jena IT security
In 2019, bm|t´s Investee-Partners raised over 85.5 Mio. EUR of equity and mezzanine capital. This marks the fourth year in a row with over 40